Research programme: anti-fungals - Prokaryotics
Alternative Names: Anti-fungal drugs - ProkaryoticsLatest Information Update: 20 Oct 2023
At a glance
- Originator Prokaryotics
- Class Antifungals
- Mechanism of Action Cell wall inhibitors; GPI-linked protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Aspergillosis; Candidiasis